Principal Securities, Inc. Xenon Pharmaceuticals Inc. Call Options Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XENE
# of Institutions
222Shares Held
69.7MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$259 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$202 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$175 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$126 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$123 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.85B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...